PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
16-Mar-2021 Data From Phase 3 Extension Study Show TREMFYA®▼ (guselkumab) Maintains Joint Efficacy and Complete Skin Clearance in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years Janssen
16-Mar-2021 PCI Broadens Clinical Trial Service Offerings at Berlin Facility PCI Pharma Services
16-Mar-2021 Newron and Zambon sign agreement for potentially pivotal study with safinamide in Parkinson’s disease patients Newron Pharmaceuticals S.p.A.
16-Mar-2021 Results from the Second Year of Evrysdi™ (risdiplam) Treatment Demonstrated Sustained Improvement of Motor Function in a Broad Range of SMA Patients SOUTH PLAINFIELD
16-Mar-2021 Pistoia Alliance Survey Finds 62 Percent of Life Science Professionals say AI will Lead to Faster R&D, but is Held Back by Skills Gap and Data Bias The Pistoia Alliance
16-Mar-2021 New two-year data show Roche’s Evrysdi (risdiplam) continues to demonstrate improvement or maintenance of motor function in people aged 2-25 with Type 2 or Type 3 Spinal Muscular Atrophy (SMA) Roche
16-Mar-2021 Subgroup Analysis from Phase 3 Clinical Trial Supports Efficacy of Maribavir Over Conventional Therapies in Transplant Recipients With Cytomegalovirus Infection (Refractory, With or Without Resistance) Takeda
15-Mar-2021 Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE® CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke W. L. Gore & Associates
15-Mar-2021 Antigen Skin Test Market 2021: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2026 ARC Report Stores
15-Mar-2021 Beckman Coulter’s Interleukin-6 test is now available for use in helping identify severe inflammatory response in COVID-19 patients Beckman Coulter
15-Mar-2021 bluebird bio Presents Long-Term Data for elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) bluebird bio
15-Mar-2021 Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival Sanofi
12-Mar-2021 Cytel’s East Bayes® Broadens & Simplifies Access to Complex Bayesian Clinical Trial Designs Cytel Inc.
12-Mar-2021 Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients Kintor Pharmaceutical
12-Mar-2021 CluePoints Sponsors RBQM Live - The Definitive Guide to RBQM for Experts and Beginners CluePoints
12-Mar-2021 Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers Xperiome
12-Mar-2021 Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate Sanofi
12-Mar-2021 Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Novavax
12-Mar-2021 CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers CD Bioparticles
11-Mar-2021 GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in Stevenage Cell and Gene Therapy Catapult